Concepedia

Mary Anné Banevicius

MA

21

Publications

946

Citations

18

H-Index

1994

Active since

Affiliations

Hartford Hospital(Current)

Hartford Financial Services (United States)

Office of Infectious Diseases

Delaware Clinical & Laboratory Physicians

Pfizer (United States)

Mary Anné Banevicius is an author at Hartford Hospital specializing in medicine, drug resistance, and antibiotics.

Top concepts

Publications per year

1994–2013

21

Publications

21

Comparative <i>In Vitro</i> and <i>In Vivo</i> Efficacies of Human Simulated Doses of Ceftazidime and Ceftazidime-Avibactam against Pseudomonas aeruginosa

Jared L. Crandon, Virna Schuck, Mary Anné Banevicius et al. · Antimicrobial Agents and Chemotherapy · 2012 · 115 citations · Full text

Adaptation-Based Resistance to Siderophore-Conjugated Antibacterial Agents by Pseudomonas aeruginosa

Andrew P. Tomaras, Jared L. Crandon, Craig J. McPherson et al. · Antimicrobial Agents and Chemotherapy · 2013 · 110 citations · Full text

Serum bactericidal activity of ceftazidime: continuous infusion versus intermittent injections

David P. Nicolau, C H Nightingale, Mary Anné Banevicius et al. · Antimicrobial Agents and Chemotherapy · 1996 · 87 citations · Full text

Determination of the In Vivo Pharmacodynamic Profile of Cefepime against Extended-Spectrum-Beta-Lactamase-Producing <i>Escherichia coli</i> at Various Inocula

Dana Maglio, Christine T. Ong, Mary Anné Banevicius et al. · Antimicrobial Agents and Chemotherapy · 2004 · 71 citations · Full text

In Vivo Pharmacodynamic Profiling of Doripenem against<i>Pseudomonas aeruginosa</i>by Simulating Human Exposures

Aryun Kim, Mary Anné Banevicius, David P. Nicolau · Antimicrobial Agents and Chemotherapy · 2008 · 62 citations · Full text

, , +26

Rows per page

1–5 of 21